Literature DB >> 6233621

Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat.

C Netti, R Bossa, I Galatulas, V Sibilia, A Pecile.   

Abstract

Cimetidine, an H2 receptor antagonist, administered into a lateral ventricle of the rat brain caused a significant increase in tail flick latency. Dimaprit, a specific H2 agonist, failed to counteract the analgesic effect of cimetidine. In contrast, it enhanced the effect of cimetidine and per se had marked analgesic activity. The specific opioid antagonist naloxone was without effect. Pretreatment with CaCl2 completely prevented the action of cimetidine. These findings suggest that the analgesic action of cimetidine and dimaprit is not due to specific effects on H2 receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233621     DOI: 10.1159/000137972

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

1.  Dimaprit--induced neurotoxicity.

Authors:  R L Swaab; A M Battles; C A Bruner; L B Hough
Journal:  Agents Actions       Date:  1992-03

2.  The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption.

Authors:  R Suojaranta-Ylinen; H Hendolin; L Tuomisto
Journal:  Agents Actions       Date:  1991-05

3.  Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.

Authors:  Amir Erfanparast; Esmaeal Tamaddonfard; Mina Taati; Milad Dabaghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-16       Impact factor: 3.000

4.  CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.

Authors:  Lindsay B Hough; Julia W Nalwalk; James G Phillips; Brian Kern; Zhixing Shan; Mark P Wentland; Iwan J P de Esch; Elwin Janssen; Travis Barr; Rebecca Stadel
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

5.  Inhibition of brain [(3)H]cimetidine binding by improgan-like antinociceptive drugs.

Authors:  Rebecca Stadel; Amanda B Carpenter; Julia W Nalwalk; Iwan J P de Esch; Elwin Janssen; Lindsay B Hough
Journal:  Eur J Pharmacol       Date:  2010-02-06       Impact factor: 4.432

6.  Antinociceptive activity of furan-containing congeners of improgan and ranitidine.

Authors:  L B Hough; W M P B Menge; A C van de Stolpe; J W Nalwalk; R Leurs; I J P de Esch
Journal:  Bioorg Med Chem Lett       Date:  2007-08-19       Impact factor: 2.823

7.  Central effects of histamine H2-receptor agonists and antagonists on nociception in the rat.

Authors:  C Netti; F Guidobono; V Sibilia; I Villa; E Cazzamalli; A Pecile
Journal:  Agents Actions       Date:  1988-04

8.  In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions.

Authors:  C Severini; G La Corte; G Improta; M Broccardo; S Agostini; C Petrella; V Sibilia; F Pagani; F Guidobono; I Bulgarelli; G L Ferri; C Brancia; A M Rinaldi; A Levi; R Possenti
Journal:  Br J Pharmacol       Date:  2009-05-19       Impact factor: 8.739

9.  Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats.

Authors:  Valeria Sibilia; Francesca Pagani; Emanuela Mrak; Elisa Dieci; Giovanni Tulipano; Francesco Ferrucci
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.